{
 "companyname": "VICAL INC",
 "symbol": "VICL",
 "description": "Biological Products, Except Diagnostic Substances",
 "quarters": [
  {
   "cik": "0000819050",
   "companyname": "VICAL INC",
   "entityid": 3939,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "VICL",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "10/30/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001564590-15-009007",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -1181000,
   "changeincurrentliabilities": 913000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -25000,
   "cashfromfinancingactivities": -2000,
   "cashfrominvestingactivities": -1086000,
   "cashfromoperatingactivities": 162000,
   "cfdepreciationamortization": 289000,
   "changeinaccountsreceivable": -1073000,
   "investmentchangesnet": -1053000,
   "netchangeincash": -926000,
   "totaladjustments": 462000,
   "ebit": -333000,
   "costofrevenue": 1306000,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 3711000,
   "incomebeforetaxes": -300000,
   "interestexpense": null,
   "netincome": -300000,
   "netincomeapplicabletocommon": -300000,
   "researchdevelopmentexpense": 2128000,
   "totalrevenue": 5017000,
   "sellinggeneraladministrativeexpenses": 1916000,
   "commonstock": 915000,
   "deferredcharges": null,
   "cashandcashequivalents": 18741000,
   "cashcashequivalentsandshortterminvestments": 41851000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 191000,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 2010000,
   "retainedearnings": -402550000,
   "totalassets": 53420000,
   "totalcurrentassets": 47620000,
   "totalcurrentliabilities": 5474000,
   "totalliabilities": 5968000,
   "totallongtermdebt": null,
   "totalreceivablesnet": 5769000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 47452000,
   "treasurystock": null
  },
  {
   "cik": "0000819050",
   "companyname": "VICAL INC",
   "entityid": 3939,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "VICL",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "7/30/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001193125-15-270353",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -901000,
   "changeincurrentliabilities": 399000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -10000,
   "cashfromfinancingactivities": -4000,
   "cashfrominvestingactivities": 4447000,
   "cashfromoperatingactivities": -2442000,
   "cfdepreciationamortization": 294000,
   "changeinaccountsreceivable": -799000,
   "investmentchangesnet": 4472000,
   "netchangeincash": 2001000,
   "totaladjustments": 320000,
   "ebit": -2792000,
   "costofrevenue": 2379000,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 1797000,
   "incomebeforetaxes": -2762000,
   "interestexpense": null,
   "netincome": -2762000,
   "netincomeapplicabletocommon": -2762000,
   "researchdevelopmentexpense": 2457000,
   "totalrevenue": 4176000,
   "sellinggeneraladministrativeexpenses": 2132000,
   "commonstock": 914000,
   "deferredcharges": null,
   "cashandcashequivalents": 19667000,
   "cashcashequivalentsandshortterminvestments": 41741000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 191000,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 2207000,
   "retainedearnings": -402250000,
   "totalassets": 52381000,
   "totalcurrentassets": 46438000,
   "totalcurrentliabilities": 4545000,
   "totalliabilities": 5163000,
   "totallongtermdebt": null,
   "totalreceivablesnet": 4697000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 47218000,
   "treasurystock": null
  },
  {
   "cik": "0000819050",
   "companyname": "VICAL INC",
   "entityid": 3939,
   "primaryexchange": "Nasdaq Global Market",
   "primarysymbol": "VICL",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/8/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 1,
   "dcn": "0001193125-15-179784",
   "currencycode": "USD",
   "crosscalculated": false,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": 366000,
   "changeincurrentliabilities": -1087000,
   "changeininventories": null,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -23000,
   "cashfromfinancingactivities": -14000,
   "cashfrominvestingactivities": 58000,
   "cashfromoperatingactivities": -2849000,
   "cfdepreciationamortization": 301000,
   "changeinaccountsreceivable": 469000,
   "investmentchangesnet": 111000,
   "netchangeincash": -2805000,
   "totaladjustments": 972000,
   "ebit": -3857000,
   "costofrevenue": 2941000,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 2003000,
   "incomebeforetaxes": -3821000,
   "interestexpense": null,
   "netincome": -3821000,
   "netincomeapplicabletocommon": -3821000,
   "researchdevelopmentexpense": 3637000,
   "totalrevenue": 4944000,
   "sellinggeneraladministrativeexpenses": 2223000,
   "commonstock": 914000,
   "deferredcharges": null,
   "cashandcashequivalents": 17666000,
   "cashcashequivalentsandshortterminvestments": 44233000,
   "goodwill": null,
   "intangibleassets": null,
   "inventoriesnet": null,
   "minorityinterest": null,
   "otherassets": 379000,
   "othercurrentassets": null,
   "othercurrentliabilities": null,
   "otherequity": null,
   "otherliabilities": null,
   "preferredstock": 0,
   "propertyplantequipmentnet": 2427000,
   "retainedearnings": -399488000,
   "totalassets": 54378000,
   "totalcurrentassets": 47942000,
   "totalcurrentliabilities": 4129000,
   "totalliabilities": 4866000,
   "totallongtermdebt": null,
   "totalreceivablesnet": 3709000,
   "totalshorttermdebt": null,
   "totalstockholdersequity": 49512000,
   "treasurystock": null
  }
 ]
}